Predicting biopsy-proven prostate cancer recurrence following cryosurgery (Q85000712)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Predicting biopsy-proven prostate cancer recurrence following cryosurgery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

Jorge R Caso

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Matvey Tsivian

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Vladimir Mouraviev

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Thomas J Polascik

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

9 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

391-395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Best practice statement on cryosurgery for the treatment of localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Primary cryoablation nadir prostate specific antigen and biochemical failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Prostate specific antigen doubling time calculation: not as easy as 1, 2, 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Prospective trial of cryosurgical ablation of the prostate: five-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.04.001

10.1016/J.UROLONC.2010.04.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20826095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference